INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 84 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $33,364 | +31.6% | 158,500 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $25,360 | -71.2% | 158,500 | 0.0% | 0.00% | -72.7% |
| Q4 2022 | $87,968 | -73.3% | 158,500 | +8.4% | 0.01% | -77.1% |
| Q4 2021 | $329,000 | -34.2% | 146,200 | 0.0% | 0.05% | -42.2% |
| Q3 2021 | $500,000 | +37.4% | 146,200 | +20.0% | 0.08% | +31.7% |
| Q2 2021 | $364,000 | +134.8% | 121,800 | +66.4% | 0.06% | +96.9% |
| Q4 2020 | $155,000 | – | 73,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
| Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
| Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
| PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
| Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
| ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |